Skip to main content
. 2020 Aug 20;2020:8164365. doi: 10.1155/2020/8164365

Table 2.

The relationship between PD-L1/CD8+ TILS density groups and clinicopathological features.

Clinicopathological features n A group B group C group D group P
Age (years)
 ≤47 51 13 (25.5) 19 (37.3) 17 (33.3) 2 (3.9) 0.473
 >47 44 8 (18.2) 21 (47.7) 10 (22.7) 5 (11.4)
Tumor size (cm)
 ≤3 51 7 (13.7) 18 (35.3) 21 (41.2) 5 (9.8) 0.473
 >3 44 14 (31.8) 22 (50.0) 6 (13.6) 2 (4.5)
Depth of interstitial infiltration (cm)
 <1/2 29 2 (6.9) 9 (31.0) 13 (44.8) 5 (17.2) 0.001
 ≥1/2 66 19 (28.8) 31 (47.0) 14 (21.2) 2 (3.0)
FIGO stage
 I~II 77 19 (24.7) 25 (32.5) 26 (33.8) 7 (9.1) 0.001
 III~IV 18 2 (11.1) 15 (83.3) 1 (5.6) 0 (0.0)
Degree of differentiation
 Moderately high differentiation 76 19 (25.0) 26 (34.2) 25 (32.9) 6 (7.9) 0.001
 Low differentiation 19 2 (10.5) 14 (73.7) 2 (10.5) 1 (5.3)
Vascular invasion
 No 48 7 (14.6) 18 (37.5) 16 (33.3) 7 (14.6) 0.918
 Yes 47 14 (29.8) 22 (46.8) 11 (23.4) 0 (0.0)
Lymph node metastasis
 No 69 15 (21.7) 21 (30.4) 26 (37.7) 7 (10.1) 0.006
 Yes 26 6 (23.1) 19 (73.1) 1 (3.8) 0 (0.0)